1. Home
  2. IHD vs MDXH Comparison

IHD vs MDXH Comparison

Compare IHD & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IHD
  • MDXH
  • Stock Information
  • Founded
  • IHD 2011
  • MDXH 2003
  • Country
  • IHD United States
  • MDXH Belgium
  • Employees
  • IHD N/A
  • MDXH N/A
  • Industry
  • IHD Investment Managers
  • MDXH
  • Sector
  • IHD Finance
  • MDXH
  • Exchange
  • IHD Nasdaq
  • MDXH Nasdaq
  • Market Cap
  • IHD 89.7M
  • MDXH 93.1M
  • IPO Year
  • IHD N/A
  • MDXH 2021
  • Fundamental
  • Price
  • IHD $5.20
  • MDXH $1.86
  • Analyst Decision
  • IHD
  • MDXH Strong Buy
  • Analyst Count
  • IHD 0
  • MDXH 2
  • Target Price
  • IHD N/A
  • MDXH $7.00
  • AVG Volume (30 Days)
  • IHD 27.7K
  • MDXH 112.7K
  • Earning Date
  • IHD 01-01-0001
  • MDXH 02-26-2025
  • Dividend Yield
  • IHD 10.32%
  • MDXH N/A
  • EPS Growth
  • IHD N/A
  • MDXH N/A
  • EPS
  • IHD N/A
  • MDXH N/A
  • Revenue
  • IHD N/A
  • MDXH $84,708,000.00
  • Revenue This Year
  • IHD N/A
  • MDXH $28.76
  • Revenue Next Year
  • IHD N/A
  • MDXH $19.91
  • P/E Ratio
  • IHD N/A
  • MDXH N/A
  • Revenue Growth
  • IHD N/A
  • MDXH 33.01
  • 52 Week Low
  • IHD $4.49
  • MDXH $1.55
  • 52 Week High
  • IHD $5.47
  • MDXH $3.85
  • Technical
  • Relative Strength Index (RSI)
  • IHD 55.82
  • MDXH 33.28
  • Support Level
  • IHD $5.11
  • MDXH $1.80
  • Resistance Level
  • IHD $5.25
  • MDXH $1.97
  • Average True Range (ATR)
  • IHD 0.06
  • MDXH 0.07
  • MACD
  • IHD 0.01
  • MDXH -0.01
  • Stochastic Oscillator
  • IHD 73.68
  • MDXH 12.50

About IHD Voya Emerging Markets High Income Dividend Equity Fund

Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.

Share on Social Networks: